# CereSonix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ceresonix

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Seed (Aug 23, 2026)
- Investors on record: 1

## About

Based in Shanghai, China, and founded in 2025, Brain-Machine Era (Shanghai) Technology Co., Ltd., trading as CereSonix, is a brain-computer interface (BCI) developer dedicated to building a next-generation human-computer interaction platform for direct interaction between the human brain and AI.
In August 2026, CereSonix raised a Seed funding led by Hua Capital Management.
The company develops non-invasive, universal, multi-functional ultrasound BCI technology products, employing functional ultrasound neuroimaging (fUSI) as the principle for acquiring neural activity signals. This non-invasive approach achieves high-throughput, long-lifespan brain activity signal readout, avoiding the immune rejection and lifespan limitations of traditional implanted electrodes. Its product, "All-in-One," is a universal, multi-functional motor BCI that integrates multiple motor intentions onto a single non-invasive platform, targeting medical rehabilitation scenarios for patients with motor dysfunctions such as stroke, spinal cord injury, ALS, and hemiplegia.
The company’s revenue is generated by providing high-performance BCI R&D and application services.
The Seed funds will be primarily used for the independent research and development and preclinical validation of the first-generation multifunctional motor brain-computer interface product "All-Round No. 1" and the non-invasive high-throughput ultrasound whole-brain interface system.

## Funding rounds

- Seed, Aug 23, 2026 — Hua Capital Management

## Investors

- Hua Capital Management (https://capitalatlas.ai/funds/hua-capital-management) — Seed